Mecapegfilgrastim for the prophylaxis of chemotherapy-induced neutropenia in locally advanced nasopharyngeal carcinoma: A prospective phase II clinical study.

Qifeng JinYonghong HuaTing JinLei WangChangjuan TaoShuang HuangWeifeng QinXiaozhong Chen

Published in: Head & neck (2024)

Mecapegfilgrastim effectively reduced the incidence of chemotherapy-induced neutropenia and FN in patients with locally advanced nasopharyngeal carcinoma.

Keyphrases

chemotherapy induced
locally advanced
phase ii
rectal cancer
clinical trial
neoadjuvant chemotherapy
open label
squamous cell carcinoma
phase ii study
radiation therapy
double blind
placebo controlled
risk factors
phase iii
study protocol
lymph node